Aehr Test Systems (AEHR) Cash & Equivalents (2010 - 2026)

Aehr Test Systems (AEHR) has reported Cash & Equivalents for 17 consecutive years, with $116.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents rose 374.37% year-over-year to $116.4 million; the trailing twelve-month figure through May 2026 stood at $116.4 million (up 374.37% YoY), and the FY2026 full-year result was $116.4 million, up 374.37% from the prior year.
• Cash & Equivalents improved to $116.4 million in Q2 2026 per AEHR's latest filing, from $36.9 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $116.4 million in Q2 2026 and bottomed at $17.2 million in Q1 2023.
• Historically, Cash & Equivalents has averaged $38.6 million across 5 years, with a median of $32.1 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents surged 587.12% in 2022, then tumbled 50.1% in 2025.
• Over 5 years, Cash & Equivalents stood at $18.9 million in 2022, then surged by 167.64% to $50.5 million in 2023, then sank by 36.22% to $32.2 million in 2024, then retreated by 4.29% to $30.8 million in 2025, then jumped by 277.36% to $116.4 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $116.4 million, $36.9 million, and $30.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.